Company Filing History:
2 out of 303 
1 out of 243 
Years Active: 2013-2019
Title: **David A. Greenbaum: Innovator in Ocular Surgical Technology**
Introduction
David A. Greenbaum, based in Costa Mesa, CA, is a notable inventor with a significant contribution to the field of ocular surgery. With a remarkable portfolio that includes three patents, he continues to push the boundaries of innovation in medical technology.
Latest Patents
One of David's latest inventions is the “Multiple Frequency Phacoemulsification Needle Driver.” This advanced system is designed to enhance ocular surgical procedures. It comprises a multiple frequency signal source, a configurable tuned output filter, and a multiple frequency ultrasonic handpiece. The signal source operates at two distinct frequencies, ensuring precise operations while addressing third harmonic frequency issues associated with the ultrasonic handpiece. Additionally, the system's design incorporates switchable passive components such as inductors, resistors, and capacitors, or alternatively, utilizes multiple similar circuits or a multi-tap transformer, showcasing his commitment to effective and innovative solutions.
Career Highlights
Throughout his career, David has held pivotal roles at respected organizations, including Abbott Medical Optics Inc. and Johnson & Johnson Surgical Vision, Inc. His experiences at these companies have greatly contributed to his understanding and expertise in the field of ocular technology.
Collaborations
In his innovative journey, David has collaborated with accomplished professionals, including David A. King and Rob Raney. These partnerships have played an essential role in furthering his inventions and enhancing their applicability in the medical industry.
Conclusion
David A. Greenbaum's contributions to ocular surgery technology through his patents demonstrate his relentless pursuit of innovation. His ability to merge scientific knowledge with practical applications continues to make a significant impact in the surgical field, improving outcomes for patients and advancing medical practices.